Immunology

SRI has deep expertise in immunology, with over 20 years of direct experience in research and biologics launches for a wide range of immunological diseases. Our expertise spans multiple indications, including rheumatology, gastroenterology, dermatology, and ophthalmology, focusing particularly on biologic treatments. SRI conducts research globally, covering key regions such as North America, South America, Western and Eastern Europe, and Asia/the Far East. This global reach enables SRI to address diverse business questions and market needs across various immunological therapeutic areas.

SRI’s immunology research portfolio includes comprehensive work on all immunological diseases, supported by robust methodologies to provide strategic insights to our clients. SRI applies Big Data Analytics as well as qualitative and quantitative research techniques to support product development, market entry, and lifecycle management for biologics. Our deep therapeutic and market knowledge helps clients optimize launch strategies and understand evolving market dynamics in immunological conditions worldwide.